Ultrasound-nanovesicles interplay for theranostics

Adv Drug Deliv Rev. 2024 Feb:205:115176. doi: 10.1016/j.addr.2023.115176. Epub 2024 Jan 9.

Abstract

Nanovesicles (NVs) are widely used in the treatment and diagnosis of diseases due to their excellent vascular permeability, good biocompatibility, high loading capacity, and easy functionalization. However, their yield and in vivo penetration depth limitations and their complex preparation processes still constrain their application and development. Ultrasound, as a fundamental external stimulus with deep tissue penetration, concentrated energy sources, and good safety, has been proven to be a patient-friendly and highly efficient strategy to overcome the restrictions of traditional clinical medicine. Recent research has shown that ultrasound can drive the generation of NVs, increase their yield, simplify their preparation process, and provide direct therapeutic effects and intelligent control to enhance the therapeutic effect of NVs. In addition, NVs, as excellent drug carriers, can enhance the targeting efficiency of ultrasound-based sonodynamic therapy or sonogenetic regulation and improve the accuracy of ultrasound imaging. This review provides a detailed introduction to the classification, generation, and modification strategies of NVs, emphasizing the impact of ultrasound on the formation of NVs and summarizing the enhanced treatment and diagnostic effects of NVs combined with ultrasound for various diseases.

Keywords: Deliver; Diagnosis; Disease; Formation; Nanovesicles; Treatment; Ultrasound.

Publication types

  • Review

MeSH terms

  • Drug Carriers*
  • Humans
  • Precision Medicine*
  • Ultrasonography

Substances

  • Drug Carriers